Lutein improves visual function in some patients with retinal degeneration: A pilot study via the internet

Optometry

Volumn 71, Issue 3, 2000, Pages 147-164

  Dagnelie, Gislin ^a   Zorge, Ingrid S ^c   McDonald, Thomas M ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b US General Accounting Office   (United States)

^c Johns Hopkins Univ Sch of Medicine ^*

Author keywords

Carotenoids; Internet; Lutein; Nutrition; Pigmentosa; Retinitis; Visual acuity; Visual field

Indexed keywords

DOCOSAHEXAENOIC ACID; VITAMIN; XANTHOPHYLL;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DIET SUPPLEMENTATION; DRUG COMBINATION; DRUG EFFECT; FEMALE; HUMAN; INTERNET; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PILOT STUDY; RETINA DEGENERATION; VISION TEST; VISUAL ACUITY; VISUAL FIELD;

ADMINISTRATION, ORAL; ADULT; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INTERNET; LUTEIN; MALE; MIDDLE AGED; PILOT PROJECTS; RETINAL DEGENERATION; VISION TESTS; VISUAL ACUITY; VISUAL FIELDS; VITAMINS;

EID: 0034149813     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. del Cerro M, Lazar ES, DiLoreto D Jr. The first decade of continuous progress in retinal transplantation. Micros Res Techn 1997;36:130-41.
2. Berson EL, Jacobiec FA. Neural retinal cell transplantation: ideal versus reality. Ophthalmology 1999;106:445-6.
3. Vingolo EM, Pelaia P, Forte R, et al. Does hyperbaric oxygen delivery rescue retinal photoreceptors in retinitis pigmentosa. [ARVO abstract]. Invest Ophthalmol Vis Sci 1997;38:S713, no. 3296.
4. Marmer RH, Parks S. Ozone treatment in retinitis pigmentosa: effect on color perception and blood gasses. Ann Ophthalmol 1998;30:161-3.
5. Marmer RH, Parks S. Ozone treatment in retinitis pigmentosa: effect on photo stress and contrast sensitivity. Ann Ophthalmol 1998;30:164-166.
6. Katznelson LA, Khoroshilova-Maslova IP, Eliseyeva RF. A new method of treatment of retinitis pigmentosa/pigmentary abiotrophy. Ann Ophthalmol 1990;22:167-72.
7. Birch DG, Anderson JL, Fish GE. Longitudinal measures in children receiving ENCAD for hereditary retinal degeneration. Doc Ophthalmol 1991;77:185-192.
8. Sapse AT. Cortisol, high cortisol diseases, and anti-cortisol therapy. Psychoneuroendocrinol 1997;22S1:S3-S10.
9. Berson EL, Remulla JFC, Rosner B, et al. Evaluation of patients with retinitis pigmentosa receiving electric stimulation, ozonated blood, and ocular surgery in Cuba. Arch Ophthalmol 1996;114:560-3.
10. Pelaez O. Evaluation of patients with retinitis pigmentosa receiving electric stimulation, ozonated blood, and ocular surgery in Cuba. Arch Ophthalmol 1997;115:133-4.
11. Gerding H. Evaluation of patients with retinitis pigmentosa receiving electric stimulation, ozonated blood, and ocular surgery in Cuba [letter; comment]. Arch Ophthalmol 1997;115:1215-6.
12. Bacal DA, Rousta S, Hertle RW, et al. Restrictive strabismus after ocular surgery for retinitis pigmentosa in Cuba [letter]. Arch Ophthalmol 1997;115:930-1.
13. Berson EL, Rosner B, Sandberg MA, et al. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa [see comments]. Arch Ophthalmol 1993;111:761-72.
14. Massof RW, Finkelstein D. Supplemental vitamin A retards loss of ERG amplitude in retinitis pigmentosa [editorial; comment]. Arch Ophthalmol 1993;111:751-4.
15. Norton EW, Marmor MF, Clowes DD, et al. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa [6 letters and discussion]. Arch Ophthalmol 1993;111:1460-5.
16. Berson EL, Rosner B, Sandberg MA, et al. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa [letter]. Arch Ophthalmol 1993;111: 1456-9.
17. Zorge I, McDonald TM, Dagnelie G. Lutein improves visual function in some patients with congenital retinal degenerations-a pilot study via Internet. Invest Ophthalmol Vis Sci 1999;40:S679 [ARVO Abstract no. 3680].
18. Bone RA, Landrum JT, Tarsis SL. Preliminary identification of the human macular pigment. Vision Res 1985; 25:1531-5.
19. Handelman GJ, Dratz EA, Reay CC, et al. Carotenoids in the human macula and whole retina. Invest Ophthalmol Vis Sci 1988;29:850-5.
20. van Kuijk FJGM, Siems WG, Sommerburg O. Carotenoid localization in human eye tissues. [ARVO abstract]. Invest Ophthalmol Vis Sci 1997;38:S1030, no. 4803.
21. van Kuijk FJGM, Hurst JS, Siems WG, et al. Carotenoid localization in human retina. [ARVO abstract]. Invest Ophthalmol Vis Sci 1999;40:S164, no. 879.
22. Muir GJ, Balashova OA, Balashov NA, et al. Lutein and zeaxanthin are present in significant quantities in the non-macular tissues of the human eye. [ARVO abstract]. Invest Ophthalmol Vis Sci 1998;39:S38, no. 167.
23. Khachik F, Englert G, Daitch CE, et al. Isolation and structural elucidation of the geometrical isomers of lutein and zeaxanthin in extracts from human plasma. J Chromatogr 1992;582:153-166.
24. Yeum KJ, Booth SL, Sadowski JA, et al. Human plasma carotenoid response to the ingestion of controlled diets high in fruits and vegetables. AmJ Clin Nutr 1996;64:594-602.
25. Landrum JT, Bone RA, Joa H, et al. A one-year study of the macular pigment: the effect of 140 days of a lutein supplement. Exp Eye Res 1997;65:57-62.
26. Hammond BR Jr, Johnson EJ, Russell RM, et al. Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci 1997;38:1795-801.
27. Snodderly DM, Johnson EJ, Hammond BR Jr, et al. Relationship of macular pigment to carotenoids in other tissues: evidence for interactions. [ARVO abstract]. Invest Ophthalmol Vis Sci 1998;39:S38, no. 165.
28. Hammond BR Jr, Fuld K, Snodderly DM. Iris color and macular pigment optical density. Exp Eye Res 1996;62:293-7.
29. Forman MR, Beecher GR, Lanza E, et al. Effect of alcohol consumption on plasma carotenoid concentrations in premenopausal women: a controlled dietary study. Am J Clin Nutr 1995;62:131-5.
30. Hammond BRJr, Curran-Celentano J, Judd S, et al. Sex differences in macular pigment optical density: relation to plasma carotenoid concentrations and dietary patterns. Vision Res 1996;36:2001-12.
31. Snodderly DM. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. AmJ Clin Nutr 1995;62:1448S-61S.
32. Landrum JT. The macular pigment: a possible role in protection from age-related macular degeneration. Adv Pharmacol 1997:38:537-56.
33. Schalch W. Carotenoids in the retina-a review of their possible role in preventing or limiting damage caused by light and oxygen. EXS 1992;62:280-98.
34. Abler AS, Chang CJ, Ful J, et al. Photic injury triggers apoptosis of photoreceptor cells. Res Commun Mol Pathol Pharmacol 1996;92:177-89.
35. Balashova OA, Balashov NA, Bernstein PS. Lutein and zeaxanthin exhibit photoprotective and anti-apoptotic activity in vitro. [ARVO abstract]. Invest Ophthalmol Vis Sci 1998;39:5129, no. 603.
36. Eye Disease Case-Control Study Group. Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol 1993;111:104-9.
37. Richer S. Part I: a protocol for the evaluation and treatment of atrophic age-related macular degeneration. J AM OPTOM ASSOC 1999;70:13-23.
38. Richer S. Part II: ARMD - Pilot (case series) environmental intervention data. J AM OPTOM ASSOC 1999;70:24-36.
39. Chug-Ahuja JK, Holden JM, Forman MR, et al. The development and application of a carotenoid database for fruits, vegetables, and selected multicomponent foods. J Am Diet Assn 1993;93:318-23.
40. Nebeling LC, Forman MR, Graubard BI, et al. Changes in carotenoid intake in the United States: the 1987 and 1992 National Health Interview Surveys. J Am Diet Assn 1997;97:991-6.
41. Le Marchand L, Hankin JH, Bach F, et al. An ecological study of diet and lung cancer in the South Pacific. Int J Cancer 1995;63:18-23.
42. Elmer PJ, Fosdick L, Tharp TM, et al. Feasibility of increasing vegetable and fruit intake for colon cancer prevention (Meeting abstract). Am Soc Prev Oncol, 19th Annual Meeting, March 8-11, 1995, Houston, Texas.
43. Yuan JM, Gago Dominguez M, Castelao JE, et al. Cruciferous vegetables in relation to renal cell carcinoma. Int J Cancer 1998;77:211-6.
44. Batieha AM, Armenian HK, Norkus EP, et al. Serum micronutrients and the subsequent risk of cervical cancer in a population-based nested case-control study. Cancer Epidemiol Biomarkers Prev 1993;2:335-9.
45. Blumberg J, Block G. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study in Finland. Nutr Rev 1994;52:242-5.
46. O'Neill ME, Thurnham DI. Intestinal absorption of beta-carotene, lycopene, and lutein in men and women following a standard meal: response curves in the triacylglycerol-rich lipoprotein fraction. Br J Nutr 1998; 79:149-59.
47. Micozzi MS, Brown ED, Edwards BK, et al. Plasma carotenoid response to chronic intake of selected foods and beta-carotene supplements in men. AmJ Clin Nutr 1992;55:1120-5.
48. Simpson KL, Chichester CO. Metabolism and nutritional significance of carotenoids. [Review] Ann Rev Nutr 1981;1:351-74.
49. Wingerath T, Sies H, Stahl W. Xanthophyll esters in human skin. Arch Biochem Biophys 1998,355:271-274.
50. Bazan NG. The metabolism of omega-3 polyunsaturated fatty acids in the eye: the possible role of docosahexaenoic acid and docosanoids in retinal physiology and ocular pathology. Prog Clin Biol Res 1989;312:95-112.
51. Converse CA, McLachlan T, Bow AC, et al. Lipid metabolism in retinitis pigmentosa. Progr Clin Biol Res 1987; 247:93-101.
52. Hoffman DR, Uauy R, Birch DG. Red blood cell fatty acid levels in patients with autosomal dominant retinitis pigmentosa. Exp Eye Res 1993;57:359-68.
53. Hoffman DR, Birch DG. Docosahexaenoic acid in red blood cells of patients with X-linked retinitis pigmentosa. Invest Ophthalmol Vis Sci 1995;36:1009-18.
54. Gong J, Rosner B, Rees DG, et al. Plasma docosahexaenoic acid levels in various genetic forms of retinitis pigmentosa. Invest Ophthalmol Vis Sci 1992;33: 2596-602.
55. Aguirre GD, Acland GM, Maude MB, et al. Diets enriched in docosahexaenoic acid fail to correct progressive rod-cone degeneration (prcd) phenotype. Invest Ophthalmol Vis Sci 1997;38:2387-407.
56. Kril JJ. Neuropathology of thiamine deficiency disorders. Metab Brain Dis 1996;11:9-17.
57. Ross NS, Hansen TP. Riboflavin deficiency is associated with selective preservation of critical flavoenzyme-dependent metabolic pathways. Biofactors 1992;3:185-90.
58. Roe DA. Riboflavin deficiency: mucocutaneous signs of acute and chronic deficiency. Semin Dermatol 1991; 10:293-5.
59. Hendricks WM. Pellagra and pellagra-like dermatoses: etiology, differential diagnosis, dermatopathology, and treatment. Semin Dermatol 1991;10:282-92.
60. Trakatellis A, Dimitriadou A, Trakatelli M. Pyridoxine deficiency: new approaches in immunosuppression and chemotherapy. Postgrad Med J 1997;73:617-22.
61. Wickramasinghe SN. Morphology, biology and biochemistry of cobalamin- and folate-deficient bone marrow cells. Baillieres Clin Haematol 1995;8:441-59.
62. van den Berg H, van Vliet T. Effect of simultaneous, single oral doses of beta-carotene with lutein or lycopene on the beta-carotene and retinyl ester responses in the triacylglycerol-rich lipoprotein fraction of men. Am J Clin Nutr 1998;68:82-9.
63. Brossard N, Croset M, Normand S, et al. Human plasma albumin transports [13C] docosahexaenoic acid in two lipid forms to blood cells. J Lip Res 1997;38:1571-82.
64. Hwang DH, Chanmugam PS, Ryan DH, et al. Does vegetable oil attenuate the beneficial effects of fish oil in reducing risk factors for cardiovascular disease? A m J Clin Nutr 1997;66:89-96.
65. Faulks RM, Hart DJ, Scott KJ, et al. Changes in plasma carotenoid and vitamin E profile during supplementation with ou palm fruit carotenoids.J Lab Clin Med 1998; 132:507-11.
66. Beecher HK. The powerful placebo. J Am Med Assoc 1955;159:1602-6.
67. Kienle GS, Kiene H. The powerful placebo effect: fact or fiction? J Clin Epidemiol 1997;50:1311-8.
68. Raasch TW, Bailey IL, Bullimore MA. Repeatability of visual acuity measurement. Optom Vis Sci 1998;75:342-8.
69. Weber U, Goerz G. [Carotenoid retinopathy. III. Reversibility]. [German] Klin Monatsbl f Augenheilk 1986; 188:20-2.